神经科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 神经科威廉亚洲博彩公司

阿尔茨海默病循证预防国际威廉亚洲博彩公司

2021-10-28 复旦大学附属华山医院神经内科 科技导报

阿尔茨海默病神经变性疾病

对阿尔茨海默病循证预防国际威廉亚洲博彩公司 作了解读。概述了阿尔茨海默病预防的具体策略、人群差异、现状及前景。

中文标题：

阿尔茨海默病循证预防国际威廉亚洲博彩公司

发布机构：

复旦大学附属华山医院神经内科

发布日期：

2021-10-28

简要介绍：

对阿尔茨海默病循证预防国际威廉亚洲博彩公司 作了解读。概述了阿尔茨海默病预防的具体策略、人群差异、现状及前景。根据威廉亚洲博彩公司 ,通过健康的生活方式(包括体重管理、体育锻炼、认知活动、良好睡眠、远离烟草等),良好的共病管理(糖尿病、高血压、高同型半胱氨酸血症、心脑血管疾病、头部外伤、抑郁等),提高教育程度以及维生素C摄入等可以预防阿尔茨海默病的发病。

相关资料下载：
[AttachmentFileName(sort=1, fileName=阿尔茨海默病循证预防国际威廉亚洲博彩公司 .pdf)] GetToolGuiderByIdResponse(projectId=1, id=8fde71c0023a491c, title=阿尔茨海默病循证预防国际威廉亚洲博彩公司 , enTitle=, guiderFrom=科技导报 , authorId=0, author=, summary=对阿尔茨海默病循证预防国际威廉亚洲博彩公司 作了解读。概述了阿尔茨海默病预防的具体策略、人群差异、现状及前景。, cover=https://img.medsci.cn/202222/1643814022043_5579292.png, journalId=0, articlesId=null, associationId=2371, associationName=复旦大学附属华山医院神经内科, associationIntro=复旦大学附属华山医院神经内科, copyright=0, guiderPublishedTime=Thu Oct 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">对阿尔茨海默病循证预防国际威廉亚洲博彩公司 作了解读。概述了阿尔茨海默病预防的具体策略、人群差异、现状及前景。根据威廉亚洲博彩公司 ,通过健康的生活方式(包括体重管理、体育锻炼、认知活动、良好睡眠、远离烟草等),良好的共病管理(糖尿病、高血压、高同型半胱氨酸血症、心脑血管疾病、头部外伤、抑郁等),提高教育程度以及维生素C摄入等可以预防阿尔茨海默病的发病。</span></p>, tagList=[TagDto(tagId=787, tagName=阿尔茨海默病), TagDto(tagId=5308, tagName=神经变性疾病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5334, appHits=199, showAppHits=0, pcHits=1166, showPcHits=5133, likes=2, shares=29, comments=8, approvalStatus=1, publishedTime=Sun Feb 06 15:58:00 CST 2022, publishedTimeString=2021-10-28, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Wed Feb 02 23:03:04 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 10:47:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=阿尔茨海默病循证预防国际威廉亚洲博彩公司 .pdf)])
阿尔茨海默病循证预防国际威廉亚洲博彩公司 .pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2093293, encodeId=6ef12093293a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10735431394, createdName=ms7000000598878159, createdTime=Wed Oct 12 03:01:41 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220385, encodeId=be261220385bf, content=<a href='/topic/show?id=a3f09e79649' target=_blank style='color:#2F92EE;'>#阿尔茨海默症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97796, encryptionId=a3f09e79649, topicName=阿尔茨海默症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:34:51 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199290, encodeId=c58911992908b, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Fri Mar 04 09:27:57 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192047, encodeId=beb2119204e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e021514320, createdName=yangshixi99, createdTime=Thu Feb 10 21:42:55 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191895, encodeId=308a1191895b8, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c5552065, createdName=为何呢, createdTime=Thu Feb 10 17:20:32 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-10-12 ms7000000598878159

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2093293, encodeId=6ef12093293a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10735431394, createdName=ms7000000598878159, createdTime=Wed Oct 12 03:01:41 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220385, encodeId=be261220385bf, content=<a href='/topic/show?id=a3f09e79649' target=_blank style='color:#2F92EE;'>#阿尔茨海默症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97796, encryptionId=a3f09e79649, topicName=阿尔茨海默症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:34:51 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199290, encodeId=c58911992908b, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Fri Mar 04 09:27:57 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192047, encodeId=beb2119204e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e021514320, createdName=yangshixi99, createdTime=Thu Feb 10 21:42:55 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191895, encodeId=308a1191895b8, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c5552065, createdName=为何呢, createdTime=Thu Feb 10 17:20:32 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-05-17 赛华佗

    #阿尔茨海默症#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2093293, encodeId=6ef12093293a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10735431394, createdName=ms7000000598878159, createdTime=Wed Oct 12 03:01:41 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220385, encodeId=be261220385bf, content=<a href='/topic/show?id=a3f09e79649' target=_blank style='color:#2F92EE;'>#阿尔茨海默症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97796, encryptionId=a3f09e79649, topicName=阿尔茨海默症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:34:51 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199290, encodeId=c58911992908b, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Fri Mar 04 09:27:57 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192047, encodeId=beb2119204e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e021514320, createdName=yangshixi99, createdTime=Thu Feb 10 21:42:55 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191895, encodeId=308a1191895b8, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c5552065, createdName=为何呢, createdTime=Thu Feb 10 17:20:32 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-03-04 1937600869

    学习了，很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2093293, encodeId=6ef12093293a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10735431394, createdName=ms7000000598878159, createdTime=Wed Oct 12 03:01:41 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220385, encodeId=be261220385bf, content=<a href='/topic/show?id=a3f09e79649' target=_blank style='color:#2F92EE;'>#阿尔茨海默症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97796, encryptionId=a3f09e79649, topicName=阿尔茨海默症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:34:51 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199290, encodeId=c58911992908b, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Fri Mar 04 09:27:57 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192047, encodeId=beb2119204e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e021514320, createdName=yangshixi99, createdTime=Thu Feb 10 21:42:55 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191895, encodeId=308a1191895b8, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c5552065, createdName=为何呢, createdTime=Thu Feb 10 17:20:32 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 yangshixi99

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2093293, encodeId=6ef12093293a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10735431394, createdName=ms7000000598878159, createdTime=Wed Oct 12 03:01:41 CST 2022, time=2022-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220385, encodeId=be261220385bf, content=<a href='/topic/show?id=a3f09e79649' target=_blank style='color:#2F92EE;'>#阿尔茨海默症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=207, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97796, encryptionId=a3f09e79649, topicName=阿尔茨海默症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:34:51 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199290, encodeId=c58911992908b, content=学习了，很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd15015596, createdName=1937600869, createdTime=Fri Mar 04 09:27:57 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192047, encodeId=beb2119204e4a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e021514320, createdName=yangshixi99, createdTime=Thu Feb 10 21:42:55 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191895, encodeId=308a1191895b8, content=努力学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db0c5552065, createdName=为何呢, createdTime=Thu Feb 10 17:20:32 CST 2022, time=2022-02-10, status=1, ipAttribution=)]
    2022-02-10 为何呢

    努力学习

    0

相关威廉亚洲博彩公司

阿尔茨海默病脑健康营养干预专家共识

中华医学会肠外肠内营养学分会脑健康营养协作组 · 2021-12-20

2022 国际共识：阿尔茨海默病tau PET显像剂¹⁸F-flortaucipir检查

国外影像科相关专家小组 · 2022-01-03

FDA开发用于工业治疗阿尔茨海默病药物威廉亚洲博彩公司 （草案）

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2021-11-03

国际中医临床实践威廉亚洲博彩公司 阿尔茨海默病

世界中医药学会联合会 · 2021-04-25

阿尔茨海默病与帕金森病步态分析的中国专家共识

中国老年保健协会阿尔茨海默病分会 · 2021-11-03

中国阿尔茨海默病痴呆诊疗威廉亚洲博彩公司 (2020年版)

中国老年保健协会 阿尔茨海默病分会研究小组 · 2021-03-14